Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Sedative effect

The sleep-promoting effects of benzodiazepines may relate to their ability to reduce hyperarous-ability and emotional tension. The anterograde amnesia produced by high doses may be due to their interference with hippocampal functions. [Pg.605]


Atopic Dermatitis. The mechanism of itching associated with atopic dermatitis remains unknown, but histamine is almost certainly involved to some extent as histamine concentrations are increased in the skin and in the plasma of patients with this disorder (39,42). Second-generation H receptor antagonists, unlike first-generation H receptor antagonists, have not been uniformly found to be effective in relieving itching in atopic dermatitis, which may be related to the absence of a sedative effect (43). [Pg.142]

The short-acting clomethia2ole [533-45-9] (1), sometimes used as therapy for sleep disorders ia older patients, shares with barbiturates a risk of overdose and dependence. Antihistamines, such as hydroxy2iae [68-88-2] (2), are also sometimes used as mild sedatives (see HiSTAMlNES AND HISTAMINE antagonists). Antidepressants and antipsychotics which have sedative effects are used to treat insomnia when the sleep disorder is a symptom of some underlyiag psychiatric disorder. [Pg.218]

SSRIs are widely used for treatment of depression, as well as, for example, panic disorders and obsessive—compulsive disorder. These dmgs are well recognized as clinically effective antidepressants having an improved side-effect profile as compared to the TCAs and irreversible MAO inhibitors. Indeed, these dmgs lack the anticholinergic, cardiovascular, and sedative effects characteristic of TCAs. Their main adverse effects include nervousness /anxiety, nausea, diarrhea or constipation, insomnia, tremor, dizziness, headache, and sexual dysfunction. The most commonly prescribed SSRIs for depression are fluoxetine (31), fluvoxamine (32), sertraline (52), citalopram (53), and paroxetine (54). SSRIs together represent about one-fifth of total worldwide antidepressant unit sales. [Pg.232]

The definition of desired therapeutic and side effects in the case of the benzodiazepines very much depends on the clinical problem in question. The sedative and hypnotic actions are desired effects in the treatment of insomnia, but undesired effects in the treatment of anxiety disorders. Effects that are usually undesired include daytime drowsiness, potentiation of the sedative effects of ethanol, and anterograde amnesia. They are mediated via the benzodiazepine site of GABAa receptors, since they can be antagonized with flumazenil. [Pg.254]

TCAs Once-a-day dosing may be prescribed for maintenance therapy. When the nurse administers the total daily dosage at night, the sedative effects promote sleep, and the adverse reactions appear less troublesome Because protriptyline may produce a mild stimulation in some patients, it is usually not given as a single bedtime dose... [Pg.290]

There is an increase in anticholinergic effects when antihistamines are administered with the monamine oxidase inhibitors (MAOIs) and additive sedative effects if administered with central nervous system depressants (eg, narcotic analgesics or alcohol). When cimetidine and loratadine are administered together there is a risk for increased loratadine levels. [Pg.328]

Pharmacodynamic tolerance to the psychomotor effects of benzodiazepines has been demonstrated after single or multiple doses (File 1985 Greenblatt and Shader 1978 Rosenberg and Chiu 1985). Pharmacodynamic tolerance to the anxiolytic effect (over a 6-month period) has not been demonstrated (Rickels et al. 1983), and clinical experience supports the view that many patients with anxiety disorders require long-term therapy with benzodiazepines or alternative antianxiety agents. An important clinical consequence of tolerance to sedative effects is observed in benzodiazepine overdoses, when patients may initially be... [Pg.123]

From time to time it has been suggested that histamine has some role in a number of behaviours and motor activity while the established and marked sedative effect of Hi receptor antagonists, mentioned at the start of this section, has consistently been considered to indicate a role for histamine in arousal and the sleep-waking cycle (see Chapter 22). [Pg.270]

Excessive activity of an endogenous ligand which is a benzodiazepine receptor inverse agonist and induces anxiety. In this case, the administration of fiumazenil should relieve anxiety in anxious patients and have no, or sedative, effects in healthy subjects. [Pg.410]

Codeine, hydrocodone, morphine, methadone, and oxycodone are substrates of the cytochrome P-450 isoenzyme CYP2D6.47 Inhibition of CYP2D6 results in decreased analgesia of codeine and hydrocodone due to decreased conversion to the active metabolites (e.g., morphine and hydromorphone, respectively) and increased effects of morphine, methadone, and oxycodone. Methadone is also a substrate of CYP3A4, and its metabolism is increased by phenytoin and decreased by cimetidine. CNS depressants may potentiate the sedative effects of opiates. [Pg.497]

Although many patients believe that dietary supplements will not interact with medications, recent literature suggests otherwise. Recently, many St. John s wort-drug interactions have been reported in the literature. Cases of patients developing symptoms of serotonin syndrome have been reported with St. John s wort alone and in concomitant therapy with other antidepressants such as monoamine oxidase inhibitors, serotonin reuptake inhibitors, and venlafaxine. St. John s wort may exacerbate the sedative effects of benzodiazepines, alcohol, narcotics, and other sedatives. St. John s wort may decrease the levels of protease inhibitors, cyclosporine, digoxin, and theophylline. [Pg.739]

Sleep and sedative effects of the atypical antipsychotics could be related to different mechanisms antagonism of 5-HT2 receptors, antihistaminic and antimus-carinic effects, and probably an a-1 noradrenergic effect. The difference in the effect on sleep between risperidone and haloperidol may be due to their differential actions on serotoninergic receptors (Trampus and Ongini 1990 Trampus et al. 1993). [Pg.440]


See other pages where Sedative effect is mentioned: [Pg.142]    [Pg.218]    [Pg.115]    [Pg.372]    [Pg.449]    [Pg.484]    [Pg.590]    [Pg.911]    [Pg.257]    [Pg.277]    [Pg.291]    [Pg.326]    [Pg.36]    [Pg.120]    [Pg.245]    [Pg.400]    [Pg.401]    [Pg.486]    [Pg.488]    [Pg.489]    [Pg.509]    [Pg.117]    [Pg.201]    [Pg.105]    [Pg.141]    [Pg.237]    [Pg.575]    [Pg.626]    [Pg.147]    [Pg.149]    [Pg.103]    [Pg.36]    [Pg.40]    [Pg.172]    [Pg.193]    [Pg.276]    [Pg.295]    [Pg.438]   


SEARCH



Alcohol, sedative effects

Antihistamines sedative effects

Antihistaminics sedative side effects

Antipsychotics sedative effects

Anxiolytic effect, sedatives

Barbiturate sedative-hypnotics pharmacologic effects

Benzodiazepine derivatives sedative effects

Benzodiazepine sedative-hypnotics pharmacologic effects

Biological sedative effect

Cimetidine sedative effect

Clonidine sedative effects

Ethanol, sedative effects

Flumazenil, a benzodiazepine receptor antagonist, is used to reverse the sedative effects of benzodiazepines after anesthesia

Haloperidol sedative effects

Histamine receptor antagonists) sedative effects

SEDS

Sedative

Sedative effect medications

Sedative effects of antihistamines

Sedative-hypnotic drugs adverse effects

Sedative-hypnotic drugs chronic abuse effects

Sedative-hypnotic drugs effects

Sedative-hypnotic effects

Sedatives adverse effects

Sedatives/hypnotics adverse effects

Side effects, sedative

© 2024 chempedia.info